menu
    • menu

    Company profile for SemaThera Inc

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SemaThera develops novel inhibitors against semaphorin 3A (SEMA 3A) for prevention and reversal of diabetic macular edema (DME). SEMA 3A is a soluble protein that promotes vascular leakage and contributes to diabetes-related macular edema. Its levels are significantly elevated in the vitreous of patients with DME as well as in several other vascular diseases of the retina. Importantly.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SemaThera IncCanada Flag
    Country
    Country
    Canada
    Address
    Address
    800-1 Westmount Square, Montreal, Québec Canada, H3Z 2P9
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://semathera.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/semathera-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Asia Pharma Expo

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SemaThera Enters into a Research Collab & Exclusive License Agreement Roche
    SemaThera Enters into a Research Collab & Exclusive License Agreement Roche

    22 Mar 2021

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/semathera-enters-into-a-research-collab-exclusive-license-agreement-roche-1619170836.pdf

    PRESS RELEASE
    22 Mar 2021
    Share Share
    Charity criticises NHSE and Vertex over Orkambi access, Sema scores, NodThera
    Charity criticises NHSE and Vertex over Orkambi access, Sema scores, NodThera

    25 Jun 2018

    // A. McConaghie PMLIVE

    http://www.pmlive.com/pharma_news/news_charity_criticises_nhs_england_and_vertex_over_orkambi_access,_sema_scores_again,_nodthera_launched_1241815

    A. McConaghie PMLIVE
    25 Jun 2018
    Share Share
    SemaThera Announces a $2MUS Financing and a Licensing Deal for China and Japan
    SemaThera Announces a $2MUS Financing and a Licensing Deal for China and Japan

    21 Mar 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180321005604/en/SemaThera-Announces-2MUS-Financing-Licensing-Deal-China

    BUSINESSWIRE
    21 Mar 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search